0001716166 2026-09-02 2026-09-02 true 0001716166 8-K/A 2026-09-02 Vivos Therapeutics, Inc. DE 001-39796 81-3224056 7921 Southpark Plaza Suite 210 Littleton CO 80120 (866) 908-4867 false false false false Common Stock, par value $0.0001 per share VVOS NASDAQ false Vivos Therapeutics, Inc. (the “Company”) is filing this Amendment (the “Amendment”) to its Current Report on Form 8-K dated September 4, 2026 and filed with the Securities and Exchange Commission on September 8, 2026 the (the “Original 8-K”) to correct the date of the Original 8-K. The Original Form 8-K used August 31, 2026 as the Date of Report. The transactions disclosed under Items 1.01 and 3.02 were consummated on September 2, 2026. This Amendment is being filed solely to reflect September 2, 2026 as the Date of Report and to amend Items 1.01 and 3.02 thereof to reflect the fact that the transactions reported in the Original 8-K were consummated on September 2, 2026.